Synthetic matrix metalloprotease inhibitors and use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 30, 1998
Issued Date -
N/A
app pub date -
Jun 5, 1994
filing date -
Nov 21, 1990
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Synthetic mammalian matrix metalloprotease inhibitors are disclosed that are useful for treating or preventing diseases wherein said diseases are caused by unwanted mammalian matrix metalloprotease activity and include skin disorders, keratoconus, restenosis, rheumatoid arthritis, wounds, cancer, angiogenesis and shock.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully